methamphetamine has been researched along with Huntington Disease in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jang, WJ; Jeong, CH; Lee, S; Ryu, IS; Son, T; Song, SH | 1 |
| Aungier, J; Cuesta, M; Morton, AJ; Ouk, K | 1 |
| Ishige, K; Ito, Y; Kosuge, Y; Osada, N | 1 |
| Aungier, J; Morton, AJ; Ouk, K | 1 |
| Aungier, J; Cuesta, M; Morton, AJ | 1 |
| Johnson, MA; Miller, CE; Rajan, V; Wightman, RM | 1 |
| Carter, RJ; Morton, AJ; Reynolds, DS | 1 |
| Adams, V; Ang, L; Anthony, RA; Falardeau, P; Furukawa, Y; Guttman, M; Kalasinsky, KS; Kish, SJ; Moszczynska, A; Reiber, G; Schmunk, G; Wickham, D; Worsley, JN | 1 |
| Costain, WJ; Crocker, SF; Denovan-Wright, EM; Hamilton, LC; MacGibbon, GA; Murphy, KM; Robertson, HA | 1 |
| Hickey, MA; Morton, AJ; Reynolds, GP | 1 |
1 review(s) available for methamphetamine and Huntington Disease
| Article | Year |
|---|---|
Mithramycin, an agent for developing new therapeutic drugs for neurodegenerative diseases.
Topics: Animals; Cell Death; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; Endoplasmic Reticulum Stress; Hippocampus; Humans; Huntington Disease; Long-Term Potentiation; Methamphetamine; Mice; Molecular Targeted Therapy; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Oxidative Stress; Plicamycin; Reperfusion Injury | 2013 |
9 other study(ies) available for methamphetamine and Huntington Disease
| Article | Year |
|---|---|
Transcriptional Profiling of Whisker Follicles and of the Striatum in Methamphetamine Self-Administered Rats.
Topics: Alzheimer Disease; Amphetamine-Related Disorders; Animals; Corpus Striatum; Disease Models, Animal; Gene Expression Regulation; Hair Follicle; High-Throughput Nucleotide Sequencing; Humans; Huntington Disease; Methamphetamine; Neostriatum; Parkinson Disease; Rats; Self Administration; Signal Transduction; Transcriptome; Vibrissae | 2020 |
Chronic paroxetine treatment prevents disruption of methamphetamine-sensitive circadian oscillator in a transgenic mouse model of Huntington's disease.
Topics: Animals; Central Nervous System Stimulants; Circadian Clocks; Circadian Rhythm; Cocaine; Disease Models, Animal; Female; Huntington Disease; Male; Methamphetamine; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Transgenic; Motor Activity; Paroxetine; Receptors, Dopamine; Selective Serotonin Reuptake Inhibitors; Serotonin; Synaptic Transmission; Vesicular Monoamine Transport Proteins | 2018 |
Progressive gene dose-dependent disruption of the methamphetamine-sensitive circadian oscillator-driven rhythms in a knock-in mouse model of Huntington's disease.
Topics: Age Factors; Animals; Central Nervous System Stimulants; Chronobiology Disorders; Circadian Rhythm; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Humans; Huntingtin Protein; Huntington Disease; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Mutation | 2016 |
The methamphetamine-sensitive circadian oscillator is dysfunctional in a transgenic mouse model of Huntington's disease.
Topics: Animals; Behavior, Animal; Biological Clocks; Central Nervous System Stimulants; Circadian Rhythm; Disease Models, Animal; Female; Huntington Disease; Male; Methamphetamine; Mice; Mice, Transgenic; Motor Activity; Suprachiasmatic Nucleus | 2012 |
Dopamine release is severely compromised in the R6/2 mouse model of Huntington's disease.
Topics: Age Factors; Animals; Cocaine; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Electrochemistry; Huntingtin Protein; Huntington Disease; In Vitro Techniques; Methamphetamine; Mice; Mice, Transgenic; Microelectrodes; Motor Activity; Nerve Tissue Proteins; Nuclear Proteins; Time Factors | 2006 |
Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington's disease.
Topics: Animals; Antihypertensive Agents; Behavior, Animal; Benzazepines; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Antagonists; Drug Interactions; Female; Huntington Disease; Methamphetamine; Microglia; Nerve Degeneration; Neurons; Nitro Compounds; Oxidopamine; Propionates; Rats; Rats, Sprague-Dawley; Substantia Nigra; Sympatholytics; Sympathomimetics | 1998 |
Dopamine D1 receptor protein is elevated in nucleus accumbens of human, chronic methamphetamine users.
Topics: Adult; Aged; Amphetamine-Related Disorders; Blotting, Western; Brain Chemistry; Chronic Disease; Cloning, Molecular; Cocaine-Related Disorders; Dopamine Agents; Heroin Dependence; Humans; Huntington Disease; Male; Methamphetamine; Middle Aged; Nucleus Accumbens; Putamen; Receptors, Dopamine D1; Receptors, Dopamine D2 | 2000 |
Immediate-early gene response to methamphetamine, haloperidol, and quinolinic acid is not impaired in Huntington's disease transgenic mice.
Topics: Animals; Anti-Dyskinesia Agents; Central Nervous System Stimulants; Corpus Callosum; Corpus Striatum; Disease Models, Animal; DNA-Binding Proteins; Dopamine and cAMP-Regulated Phosphoprotein 32; Dopamine Antagonists; Early Growth Response Protein 1; Gene Expression; Genes, Immediate-Early; Glial Fibrillary Acidic Protein; Haloperidol; Huntington Disease; Immediate-Early Proteins; Methamphetamine; Mice; Mice, Transgenic; Nerve Tissue Proteins; Phosphoproteins; Proto-Oncogene Proteins c-fos; Quinolinic Acid; RNA, Messenger; Transcription Factors | 2002 |
The role of dopamine in motor symptoms in the R6/2 transgenic mouse model of Huntington's disease.
Topics: Aging; Animals; Behavior, Animal; Brain; Brain Chemistry; Central Nervous System Stimulants; Cocaine; Diabetes Complications; Diabetes Mellitus; Disease Models, Animal; Disease Progression; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Female; Glucose Tolerance Test; Huntington Disease; Levodopa; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Spatial Behavior; Survival Rate | 2002 |